ReviewCurrent hematologic malignancy reports2019

Induced Pluripotent Stem Cell (iPSC)-Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges.

Alexandros Nianias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.